Abstract
Nateglinide and mitiglinide (glinides) are characterized as rapid-onset and short-acting insulinotropic agents. Although both compounds do not have a sulfonylurea structure, it has been postulated that insulin secretion is preceded by their binding to Kir6.2/SUR1 complex, and a mechanism of insulin secretion of glinides has been accounted for by this pathway. However, we hypothesized the involvement of additional mechanisms of insulin secretion enhanced by glinides, and we analyzed the pattern of time course of insulin secretion from MIN6 cells with the existence of agents that have specific pharmacologic actions. Dose-dependent effects of tolbutamide, glibenclamide, nateglinide, and mitiglinide were observed. Insulin secretion induced by 3 μM tolbutamide and 1 nM glibenclamide was completely inhibited by 10 μM diazoxide and 3 μM verapamil, although the latter half-component of insulin secretion profile induced by 3 μM nateglinide or 30 nM mitiglinide remained with the existence of those agents. Glinides enhanced insulin secretion even in Ca2+-depleted medium, and its pattern of secretion was same as the pattern with existence of verapamil. The latter half was suppressed by 1 μM dantrolene, and concomitant addition of verapamil and dantrolene completely suppressed the entire pattern of insulin secretion enhanced by nateglinide. Thus, we conclude that glinide action is demonstrated through two pathways, dependently and independently, from the pathway through KATP channels. We also demonstrated that the latter pathway involves the intracellular calcium release from endoplasmic reticulum via ryanodine receptor activation.
Footnotes
-
This study has been approved by the Animal Use Committee of the Kawasaki Medical School (03-093) and was conducted in compliance with the Animal Use Guidelines of the Kawasaki Medical School. This work is supported by a Grant-in-aid for Scientific Research 18591008 (to K.K.) and Research Project Grant 18-501 (to K.K.).
-
Article, publication date, and citation information can be found at http://jpet.aspetjournals.org.
-
doi:10.1124/jpet.107.120592.
-
ABBREVIATIONS: SUR, sulfonylurea receptor; GSIS, glucose-stimulated insulin secretion; ER, endoplasmic reticulum; PBS, phosphate-buffered saline; KATP channel, ATP-sensitive potassium channel; KRBH, Krebs-Ringer-bicarbonate HEPES buffer; LDH, lactate dehydrogenase.
- Received January 25, 2007.
- Accepted April 3, 2007.
- The American Society for Pharmacology and Experimental Therapeutics
JPET articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|